BioTrinity Testimonials 2011


All testimonials are reproduced with kind permission from their authors, and were comments received in the days and weeks following BioTrinity's emergence as the largest biopartnering conference in the UK.  Nearly 100 testimonials were received after BioTrinity 2011, for which we are very grateful, just a few of these are listed below:

Richard Wilson, Director, Global Strategic Alliances, Novartis, "Tremendous event - There are so many of these partnering meetings nowadays, but BioTrinity is not too big, not too small and has a terrific blend across therapeutic areas encompassing novel platform companies, and the showcasing of interesting preclinical and clinical stage assets."


Charles Sermon, Partner, Phase4 Ventures, "This was my first BioTrinity and it was well attended, well organised and a very useful networking opportunity. Tuesday’s dinner was also really helpful VC networking forum in a great venue."

 


Shawn Manning, Life Sciences Analyst, Singer Capital Markets, “Again a great event, great panel presentations, wonderful company presentations, an opportunity to meet a whole host of companies in a relatively short space of time and in the last two days, I’ve met 23 new companies, including new spin out companies.  A brilliant conference!”

 


John Beadle, CEO, PsiOxus Therapeutics, "Yet again the BioTrinity meeting provided an ideal venue for meeting with our past, current and future business partners."


Will West, CEO CellCentric, "BioTrinity has proven a highly efficient and productive forum for us to do business as all our key investor and business development contacts attend. A premier International meeting and a key event in our calendar – definitely not one to miss."


Dr Richard Goodfellow, Scancell Holdings plc, “BioTrinity has come a long way in recent years. It is now my partnering conference of choice in the UK”.


Anthony Brown, Director of Business Development, CRT, “The BioTrinity poster showcase resulted in two of our academics setting being asked to meetings with pharmaceutical companies”


Sofia Ioannidou, Edmond de Rothschild Investment Partners, “BioTrinity is a very good opportunity to get a comprehensive view of the biotech and pharma scene in the UK at the moment”.


John Brehm, Health Protection Agency, “BioTrinity is an absolute must event to attend for those who wish to network and advance in the bioscience community”.


Andrew Barrett, Malvern Cosmeceutics, “BioTrinity 2011 featured a plethora of delegates with a positive and collaborative attitude. My best partnering meeting ever: I'll be back!”.


Sue Morley, Lab Support ,“BioTrinity has always been a good event for us, this year particularly, we spoke with more prospective clients and took two new orders. Definitely worth the trip!!”


Martino Picardo, Stevenage Bioscience Catalyst,“I really enjoyed BioTrinity and we at Stevenage Bioscience Catalyst derived a lot of benefit from the meeting”.


Dr Laura Etchells, University of Manchester Incubator Company, “I wanted to establish early links with investors and potential licensees-this was fully achievable thanks to the well organised one-to-one partnering sessions made available through BioTrinity”.



Diana Morgan, Avanticell, “BioTrinity is the best life science partnering meeting held in the UK”


Julian Rae, RSSL, “BioTrinity allowed me to meet with like minded people in the bio and pharma industries in a friendly and open manner.  The diversity of the delegates was an unexpected positive that will lead to partnerships long into the future”.


Howard Sherman, CFO, Safeguard Biosystems, “The one-to-one partnering was of an extremely high quality and we were particularly impressed”


Andrea Baines, University of Oxford, “We went to BioTrinity with the hope of raising the profile of a new project and this hope was met and exceeded. We're looking forward to returning next year”.


Dr Carlos Pittol, Director, Clubb Capital, “A very well organised and well attended event, making it one of the top biopartnering conferences in the UK”.


Simon McEwen, Director, McEwen Laboratories, “BioTrinity is an excellent opportunity to develop business contacts and showcase your companies' capabilities”





BioTrinity 2014 highlights
1,014 delegates from 32 countries
624 companies
184 speakers
107 company showcase presentations
2,462 one-to-one meetings
130+ investor delegates from 12 countries
61 exhibitors
86 global pharma/medtech delegates
33 corporate venture delegates